Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • 2026
  • September
  • Page 78
Posted inBiotechnology

Schrödinger births new immunology and inflammation biotech, Tectora Therapeutics

September 8, 2026
Schrödinger announced the launch of new immune disease-focused Tectora Therapeutics, which comes online with a $55 million series A financing…
Read More
mutant-tp53-traps-foxp3,-disrupting-pd-l1-control-and-fueling-immune-evasion-in-lung-cancer
Posted inBiotechnology

Mutant TP53 traps FOXP3, disrupting PD-L1 control and fueling immune evasion in lung cancer

September 8, 2026
Immune checkpoint inhibitors have transformed the treatment of lung adenocarcinoma, yet they fail in nearly half of the patients who…
Read More
meprin-β-enzyme-selectively-blocked-by-its-own-synthetic-propeptide
Posted inBiotechnology

Meprin β enzyme selectively blocked by its own synthetic propeptide

September 8, 2026
Meprin β is specifically inhibited by its cognate synthetic propeptide In a development that could reshape how scientists approach diseases…
Read More
regenerative-medicine-in-the-bronze-age:-mscs-and-msc-evs-leading-the-way
Posted inGenetics

Regenerative Medicine in the Bronze Age: MSCs and MSC-EVs Leading the Way

September 8, 2026
Sponsored content brought to you by Immunotherapies have dominated cell and gene therapy for the past 5–10 years, but the…
Read More
deep-learning-framework-predicts-vaccine-immunogenicity-through-personalized-reverse-vaccinology
Posted inBiotechnology

Deep learning framework predicts vaccine immunogenicity through personalized reverse vaccinology

September 8, 2026
Personalized cancer vaccines promise to teach a patient’s immune system to attack their tumor and nothing else, but the field…
Read More
tracking-non-tuberculous-mycobacteria-in-ukrainian-patients-from-2022-to-2024
Posted inBiotechnology

Tracking non-tuberculous mycobacteria in Ukrainian patients from 2022 to 2024

September 8, 2026
Scientists working under wartime conditions have produced the first systematic genomic map of non-tuberculous mycobacteria (NTM) in Ukraine, revealing a…
Read More
mixed-food-additives-linked-to-higher-hypertension-and-heart-disease-risk
Posted inBiotechnology

Mixed food additives linked to higher hypertension and heart disease risk

September 8, 2026
One of the largest investigations into the health effects of food additives ever conducted suggests that the real risk may…
Read More
peer-navigators-using-mobile-dot-help-justice-involved-people-with-hiv
Posted inBiotechnology

Peer navigators using mobile DOT help justice-involved people with HIV

September 8, 2026
People leaving jail or prison with HIV face some of the steepest odds in modern medicine. The disruption of incarceration—of…
Read More
genetic-risk-score-improves-glaucoma-screening-in-large-population-cohort
Posted inBiotechnology

Genetic risk score improves glaucoma screening in large population cohort

September 8, 2026
Glaucoma, a silent thief of sight that affects roughly three percent of the elderly population, has long frustrated public health…
Read More
rnav8-bio-joins-arpa-h-team-to-pioneer-programmable-rna-medicines
Posted inGenetics

RNAV8 Bio Joins ARPA-H Team to Pioneer Programmable RNA Medicines

September 8, 2026
Credit: Anilakkus/Getty Images RNAV8 Bio (pronounced Renovate Bio) has been selected to receive funding from the Advanced Research Projects Agency…
Read More

Posts pagination

Previous page 1 … 76 77 78 79 80 … 109 Next page

Privacy Policy    Terms

Scroll to Top